Minimal Residual Disease Status as a Surrogate Endpoint for...

  • Main
  • 2019 / 10
  • Minimal Residual Disease Status as a Surrogate Endpoint for...

Minimal Residual Disease Status as a Surrogate Endpoint for Progression-Free Survival in Newly Diagnosed Multiple Myeloma Studies: A Meta-analysis

Avet-Loiseau, Hervé, Ludwig, Heinz, Landgren, Ola, Paiva, Bruno, Morris, Chris, Yang, Hui, Zhou, Kefei, Ro, Sunhee, Mateos, Maria-Victoria
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2019.09.622
Date:
October, 2019
File:
PDF, 2.70 MB
english, 2019
Conversion to is in progress
Conversion to is failed